Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
St. Jude Children's Research Hospital
Fudan University
British Columbia Cancer Agency
Excel Diagnostics and Nuclear Oncology Center